• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Siemens expects medical restructuring

Article

Add Siemens to the list of European companies planning to restructuretheir medical divisions. The German vendor announced this monththat it intends to retool its Medical Engineering Group to cometo grips with changes in healthcare in two major markets,

Add Siemens to the list of European companies planning to restructuretheir medical divisions. The German vendor announced this monththat it intends to retool its Medical Engineering Group to cometo grips with changes in healthcare in two major markets, theU.S. and Germany.

The announcement came as Siemens released year-end financialresults that indicated that the company enjoyed a healthy fiscal1996, with both revenues and profits up. Siemens warned, however,that it expected net income to be flat in 1997 due to decliningearnings in the firm's components segment, as well as an expectedrestructuring in the Medical Engineering Group.

"Earnings in the Medical Engineering Group were affectedby ongoing cost-cutting measures in the healthcare industry, particularlyin Germany and the U.S., and by sharply eroding prices,"the company said. "Additional productivity-enhancing measurescouldn't compensate for these factors."

Siemens has not yet released details on how it will restructurethe Medical Engineering Group, although it may give more informationat the upcoming Radiological Society of North America meeting,according to a spokesperson for the vendor's Siemens Medical SystemsU.S. subsidiary in Iselin, NJ.

For the year, Siemens reported revenues of 94.2 billion deutschemarks ($62.08 billion), up 6% compared with 88.8 billion DM ($58.52billion) in 1995. Net income before extraordinary items stoodat 2.49 billion DM ($1.64 billion), compared with net income of2.08 billion DM ($1.37 billion).

The medical group reported sales of 7.1 billion DM ($4.68 billion),up 4% compared with revenues of 6.8 billion DM ($4.48 billion)in fiscal 1995.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.